Literature DB >> 21269673

Histamine receptor H1 signaling on dendritic cells plays a key role in the IFN-γ/IL-17 balance in T cell-mediated skin inflammation.

Béatrice Vanbervliet1, Mübeccel Akdis, Marc Vocanson, Aurore Rozières, Josette Benetière, Paul Rouzaire, Cezmi A Akdis, Jean-François Nicolas, Ana Hennino.   

Abstract

BACKGROUND: The diverse effects of histamine on immune regulation are a result of the differential expression and regulation of 4 histamine receptors. Many of the immediate allergic and inflammatory actions of histamine are mediated via the type 1 receptor (H1R).
OBJECTIVES: We hypothesized that H1R was involved in the fine-tuning of the initiation of T cell-mediated skin pathology-that is, dermatitis.
METHODS: The impact of the H1R invalidation on the development of skin inflammation was analyzed in a mouse model of atopic dermatitis.
RESULTS: We show that H1r(-)/(-) mice developed reduced allergen-specific skin lesions. Lack of H1R expression on dendritic cells (DCs) led to diminished IL-12, upregulated IL-23, and IL-6 production upon allergen stimulation. H1R engagement on dendritic cells was necessary for DC activation and subsequent priming of effector IFN-γ(+)CD8(+) T cells. We demonstrate here that H1R blockade on DCs promotes generation of noneffector IL-17(+)CD8(+) T cells that are unable to initiate the skin inflammation.
CONCLUSION: Our data identify that histamine signaling through the H1R on DCs is an important early event conditioning the quality of the skin effector immune response.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269673     DOI: 10.1016/j.jaci.2010.12.002

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

1.  Functional selectivity induced by mGlu₄ receptor positive allosteric modulation and concomitant activation of Gq coupled receptors.

Authors:  Shen Yin; Rocio Zamorano; P Jeffrey Conn; Colleen M Niswender
Journal:  Neuropharmacology       Date:  2012-03-09       Impact factor: 5.250

2.  Dynamic analysis of histamine-mediated attenuation of acetylcholine-induced sweating via GSK3β activation.

Authors:  Saki Matsui; Hiroyuki Murota; Aya Takahashi; Lingli Yang; Jeong-Beom Lee; Kouta Omiya; Masato Ohmi; Junichi Kikuta; Masaru Ishii; Ichiro Katayama
Journal:  J Invest Dermatol       Date:  2013-07-30       Impact factor: 8.551

3.  H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis.

Authors:  Naresha Saligrama; Rajkumar Noubade; Laure K Case; Matthew E Poynter; Cory Teuscher
Journal:  Cell Immunol       Date:  2012-07-14       Impact factor: 4.868

4.  Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomas.

Authors:  Brian Ahn; Gary Kohanbash; Takayuki Ohkuri; Akemi Kosaka; Xiaowei Chen; Maki Ikeura; Timothy C Wang; Hideho Okada
Journal:  Oncoimmunology       Date:  2015-05-26       Impact factor: 8.110

Review 5.  Cytokine control of inflammation and repair in the pathology of multiple sclerosis.

Authors:  Jane M Rodgers; Stephen D Miller
Journal:  Yale J Biol Med       Date:  2012-12-13

6.  The H1-receptor antagonist cetirizine ameliorates high-fat diet-induced glucose intolerance in male C57BL/6 mice, but not diabetes outcome in female non-obese diabetic (NOD) mice.

Authors:  Ebrahim Anvari; Xuan Wang; Stellan Sandler; Nils Welsh
Journal:  Ups J Med Sci       Date:  2014-10-07       Impact factor: 2.384

7.  Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens.

Authors:  Cezmi A Akdis; Mübeccel Akdis
Journal:  World Allergy Organ J       Date:  2015-05-14       Impact factor: 4.084

8.  Expression and function of histamine and its receptors in atopic dermatitis.

Authors:  M Albrecht; A M Dittrich
Journal:  Mol Cell Pediatr       Date:  2015-12-21

Review 9.  New insights into atopic dermatitis: role of skin barrier and immune dysregulation.

Authors:  Donald Y M Leung
Journal:  Allergol Int       Date:  2013-06       Impact factor: 5.836

Review 10.  Mast Cells: A New Frontier for Cancer Immunotherapy.

Authors:  Jake N Lichterman; Sangeetha M Reddy
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.